Clinical trials
Active, not recruiting Anemia, Sickle Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 13 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 8 |
| Children's Hospital Medical Center, Cincinnati | 4 |
| Vanderbilt University Medical Center | 4 |
| City of Hope Medical Center | 3 |
| Agios Pharmaceuticals, Inc. | 2 |
| David Williams | 2 |
| Emory University | 2 |
| Indiana University | 2 |
| Novartis Pharmaceuticals | 2 |
| St. Jude Children's Research Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 57 |
| beta-Thalassemia | 6 |
| Hemoglobinopathies | 5 |
| Graft vs Host Disease | 4 |
| Hematologic Diseases | 4 |
| Sickle Cell Trait | 4 |
| Thalassemia | 4 |
| Vaso-Occlusive Crises | 4 |
| Anemia, Hemolytic | 3 |
| Anemia | 2 |
Trials
Showing 76 to 57 of 57. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.